Reuters logo
BRIEF-TG Therapeutics announces successful outcome from first pre-planned interim analysis
August 10, 2017 / 11:45 AM / 4 months ago

BRIEF-TG Therapeutics announces successful outcome from first pre-planned interim analysis

Aug 10 (Reuters) - TG Therapeutics Inc

* TG Therapeutics Inc announces successful outcome from the first pre-planned interim analysis by independent DSMB of the DLBCL cohort in the unity-NHL PHASE 2B trial

* TG Therapeutics Inc - ‍DSMB recommends continued enrollment in TGR-1202 + TG-1101 arm and no further enrollment into single agent TGR-1202 arm​

* TG Therapeutics Inc - ‍single agent TGR-1202 arm will be replaced with triple combination of TG-1101, TGR-1202 and bendamustine​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below